Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2021 Q2- Text added to 2021 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
avoid, colorectal, elevated, greater, highlighting, index, infiltrating, KEYTRUDA, lessor, lung, Merck, move, mutated, newest, pancreatic, passed, pembrolizumab, pharmacodynamic, pipeline, promising, rapidly, reclaim, released, Request, shrinkage, trend, twelve, type
Removed:
advancing, capacity, COVID, expanded, observed, qualified, sublease
Valuein 2021 Q2 filing- Value in 2021 Q3 filing
Original filings
Filing view